← Back to all trials
Not Yet Recruiting
NCT05698160
Biomarkers and Prediction of Tigecycline Induced Coagulation Dysfunction
Conditions: Blood Coagulation Disorder
Sex: All
Ages: 18 Years – N/A
Enrollment: 200
Sponsor: The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Summary
This study is to screen out the biomarkers and establish the model to predict coagulation dysfunction induced tigecycline
Eligibility Criteria
Inclusion Criteria:Inpatients receiving tigecycline treatment in the Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical SchoolIntravenous tigecycline ≥ 3 daysMonitoring the plasma concentration of tigecyclineExclusion Criteria:Missing clinical data
Source: ClinicalTrials.gov (NCT05698160). StuddyBuddy aggregates publicly available trial information.
